Skip to content
HowShorted

Omeros Corporation short interest in 2024

In 2024, Omeros Corporation's disclosed short interest ran from 21.98% of shares outstanding on 12 Jan 2024 to 14.56% on 31 Dec 2024, a change of -7.42 percentage points. The year's high was 23.42% on 30 Apr 2024 and its low 14.30% on 13 Dec 2024, averaging 20.76% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 63.89 days on 31 Oct 2024. Full history: Omeros Corporation.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Omeros Corporation in 2024

2024 in figures

Start of year
21.98% (12 Jan 2024)
End of year
14.56% (31 Dec 2024)
Change
-7.42 pp
High
23.42% (30 Apr 2024)
Low
14.30% (13 Dec 2024)
Average
20.76%
Highest days to cover
63.89 (31 Oct 2024)
SEC filings marked
8

Every report in 2024

Omeros Corporation short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202421.98%19.54
31 Jan 202421.77%20.15
15 Feb 202422.00%19.03
29 Feb 202421.99%25.90
15 Mar 202421.63%28.41
28 Mar 202422.93%41.03
15 Apr 202422.66%26.6210-K filed, results (8-K)
30 Apr 202423.42%52.51
15 May 202423.37%57.3410-Q filed, results (8-K)
31 May 202422.52%40.38
14 Jun 202422.84%26.40
28 Jun 202422.15%37.67
15 Jul 202422.24%54.63
31 Jul 202421.26%28.77
15 Aug 202420.17%24.3010-Q filed, results (8-K)
30 Aug 202419.98%49.70
13 Sep 202420.44%43.78
30 Sep 202420.59%47.64
15 Oct 202420.91%56.90
31 Oct 202420.67%63.89
15 Nov 202418.51%6.2610-Q filed, results (8-K)
29 Nov 202415.39%5.88
13 Dec 202414.30%11.01
31 Dec 202414.56%6.00

See also: Omeros Corporation's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.